Restless legs syndrome (RLS) is a sensorimotor disorder with an age-dependent prevalence of up to 10% in the general population above 65 years of age. Affected individuals suffer from uncomfortable sensations and an urge to move in the lower limbs that occurs mainly in resting situations during the evening or at night. Moving the legs or walking leads to an improvement of symptoms. Concomitantly, patients report sleep disturbances with consequences such as reduced daytime functioning. We conducted a genome-wide association study (GWA) for RLS in 922 cases and 1,526 controls (using 301,406 SNPs) followed by a replication of 76 candidate SNPs in 3,935 cases and 5,754 controls, all of European ancestry. Herein, we identified six RLS susceptibility loci of genome-wide significance, two of them novel: an intergenic region on chromosome 2p14 (rs6747972, P = 9.03 × 10−11, OR = 1.23) and a locus on 16q12.1 (rs3104767, P = 9.4 × 10−19, OR = 1.35) in a linkage disequilibrium block of 140 kb containing the 5′-end of TOX3 and the adjacent non-coding RNA BC034767.
Vyšlo v časopise: Genome-Wide Association Study Identifies Novel Restless Legs Syndrome Susceptibility Loci on 2p14 and 16q12.1. PLoS Genet 7(7): e32767. doi:10.1371/journal.pgen.1002171 Kategorie: Research Article prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pgen.1002171
1. AllenRPPicchiettiDHeningWATrenkwalderCWaltersAS 2003 Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. Sleep Med 4 101 119
2. WinkelmannJSchormairBLichtnerPRipkeSXiongL 2007 Genome-wide association study of restless legs syndrome identifies common variants in three genomic regions. Nat Genet 39 1000 1006
3. StefanssonHRyeDBHicksAPeturssonHIngasonA 2007 A genetic risk factor for periodic limb movements in sleep. N Engl J Med 357 639 647
4. SchormairBKemlinkDRoeskeDEcksteinGXiongL 2008 PTPRD (protein tyrosine phosphatase receptor type delta) is associated with restless legs syndrome. Nat Genet 40 946 948
5. EngstromPGFredmanDLenhardB 2008 Ancora: a web resource for exploring highly conserved noncoding elements and their association with developmental regulatory genes. Genome Biol 9 R34
6. KikutaHLaplanteMNavratilovaPKomisarczukAZEngstromPG 2007 Genomic regulatory blocks encompass multiple neighboring genes and maintain conserved synteny in vertebrates. Genome Res 17 545 555
7. YuanSHQiuZGhoshA 2009 TOX3 regulates calcium-dependent transcription in neurons. Proc Natl Acad Sci U S A 106 2909 2914
8. EastonDFPooleyKADunningAMPharoahPDThompsonD 2007 Genome-wide association study identifies novel breast cancer susceptibility loci. Nature 447 1087 1093
9. MercerTRDingerMEMattickJS 2009 Long non-coding RNAs: insights into functions. Nat Rev Genet 10 155 159
10. DittmerSKovacsZYuanSHSiszlerGKöglM 2011 TOX3 is a neuronal survival factor that induces transcription depending on the presence of CITED1 or phosphorylated CREB in the transcriptionally active complex. J Cell Sci 124 252 60
11. MeisingerCProkischHGiegerCSoranzoNMehtaD 2009 A genome-wide association study identifies three loci associated with mean platelet volume. Am J Hum Genet 84 1 66 71
12. WacholderSHartgePPrenticeRGarcia-ClosasMFeigelsonHS 2010 Performance of common genetic variants in breast-cancer risk models. N Engl J Med 362 986 993
13. LangoHPalmerCNMorrisADZegginiEHattersleyAT 2008 Assessing the combined impact of 18 common genetic variants of modest effect sizes on type 2 diabetes risk. Diabetes 57 3129 3135
14. van HoekMDehghanAWittemanJCvan DuijnCMUitterlindenAG 2008 Predicting type 2 diabetes based on polymorphisms from genome-wide association studies: a population-based study. Diabetes 57 3122 3128
15. WichmannHEGiegerCIlligT 2005 KORA-gen–resource for population genetics, controls and a broad spectrum of disease phenotypes. Gesundheitswesen 67 Suppl 1 S26 30
16. HappeSVennemannMEversSBergerK 2008 Treatment wish of individuals with known and unknown restless legs syndrome in the community. J Neurol 255 1365 1371
17. PardiniBNaccaratiAPolakovaVSmerhovskyZHlavataI 2009 NBN 657del5 heterozygous mutations and colorectal cancer risk in the Czech Republic. Mutat Res 666 64 67
18. Cournu-RebeixIGeninELerayEBabronMCCohenJ 2008 HLA-DRB1*15 allele influences the later course of relapsing remitting multiple sclerosis. Genes Immun 9 570 574
19. YoungTPaltaMDempseyJPeppardPENietoFJ 2009 Burden of sleep apnea: rationale, design, and major findings of the Wisconsin Sleep Cohort study. Wmj 108 246 249
20. Affymetrix Inc. 2007 BRLMM-P: a Genotype Calling Method for the SNP 5.0 Array. http://www.affymetrix.com/support/technical/whitepapers.affx. Accessed 03. December 2010
21. PurcellSNealeBTodd-BrownKThomasLFerreiraMA 2007 PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81 559 575
22. DevlinBRoederK 1999 Genomic control for association studies. Biometrics 55 997 1004
23. KangHMSulJHServiceSKZaitlenNAKongSY 2010 Variance component model to account for sample structure in genome-wide association studies. Nat Genet 42 348 54
24. DevlinBBacanuSARoederK 2004 Genomic controls to the extreme. Nat Genet 36 1129 1130
25. SkolADScottLJAbecasisGRBoehnkeM 2006 Joint analysis is more efficient than replication-based analysis for two-stage genome-wide association studies. Nat Genet 38 209 213
26. StadenRBealKFBonfieldJK 2000 The Staden package, 1998. Methods Mol Biol 132 115 130
Zvýšte si kvalifikáciu online z pohodlia domova
Nemáte účet? Registrujte sa
Zadajte e-mailovú adresu, s ktorou ste vytvárali účet. Budú Vám na ňu zasielané informácie k nastaveniu nového hesla.
